前列腺癌CAR-T细胞疗法:目前的进展和未来的前景
Maria Luisa Calabrò1, Roberta Ettari1, Carla Di Chio1
1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Stagno d'Alcontres 31, 98166 Messina, Italy.
Biomedicines
|October 29, 2025
概括
化学抗原受体 (CAR) T细胞疗法在治疗转移性割抵抗性前列腺癌方面显示出前景. 本综述探讨了目前的战略,挑战和未来的方向,以推进前列腺癌治疗中的CAR-T细胞疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 前列腺癌是全球男性癌症死亡的主要原因.
- 转移性割抵抗性前列腺癌 (mCRPC) 的治愈治疗选择有限.
- 化学抗原受体 (CAR) T细胞疗法已经改变了血液恶性瘤的治疗方法,并正在探索固体瘤.
研究的目的:
- 审查目前的前列腺癌免疫治疗策略.
- 为了突出最近在治疗前列腺癌的CAR-T细胞疗法的进展.
- 确定挑战,并提出解决方案,以有效的CAR T细胞疗法在mCRPC.
主要方法:
- 对前列腺癌免疫治疗现有文献的综述.
- 对前列腺癌中CAR T细胞治疗的临床前和临床数据的分析.
- 讨论与瘤相关的抗原,疗效障碍和克服策略.
主要成果:
- 目前前前列腺癌的免疫疗法包括检查点抑制剂,疫苗和双特异性抗体.
- 卡尔T细胞疗法针对前列腺癌中的特定抗原,目前正在进行研究和临床试验.
- 关键的挑战包括抗原异质性,免疫抑制瘤微环境,毒性和T细胞持久性.
结论:
- 卡尔T细胞疗法对mCRPC治疗具有显著的潜力.
- 克服抗原向和瘤微环境等障碍对于临床成功至关重要.
- 需要一个转化路线图来推进前列腺癌患者的CAR T细胞治疗.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.3K
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
